← Back to graph

Vaccine

Arexvy GSK RSV adjuvanted

Selected indexed studies

Respiratory Syncytial Virus Prevention in the Adult Population: State of the Art. (Semin Respir Crit Care Med, 2025) [PMID:40480248]
Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines. (Vaccines (Basel), 2025) [PMID:40006644]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines. (2025) pubmed
Respiratory Syncytial Virus Prevention in the Adult Population: State of the Art. (2025) pubmed

Local graph